Cone-beam CT acquisition during transradial TACE made easy; use of the swivel arm board

Pua, Uei; Teo, Chia Chia; U, Pe Thet; Quek, Lawrence Han Hwee

doi:10.1259/bjr.20170248

Cited by 3 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Under direct fluoroscopic visualization, a 0.035-inch angled J-tip Glidewire (150-230 cm in length) and a 5-Fr, 110-to-125 cm diagnostic catheters are advanced coaxially into the descending aorta, and selective catheterization and angiography of the celiac trunk, hepatic artery, and superior mesenteric artery are performed. For super-selective catheterization and angiography, a microcatheter (135 or 150 cm in length; 1.9-2.8 Fr in diameter) is used (8,13,30,31). TACE is performed using lipiodol emulsion (Lipiodol Ultra-Fluid, Guerbet) and doxorubicin hydrochloride, followed by the administration of gelatin sponge particles (150-350 μm) mixed with contrast material until flow stasis of the tumor-feeding arteries is achieved (Fig.…”

Section: Clinical Applications Transarterial Chemoembolization For Hementioning

confidence: 99%

See 1 more Smart Citation

Update on Transradial Access for Percutaneous Transcatheter Visceral Artery Embolization

et al. 2021

View full text Add to dashboard Cite

Transfemoral access (TFA) is a widely used first-line approach for most peripheral vascular interventions. Since its introduction in cardiologic and neurointerventional procedures, several advantages of transradial access (TRA) over TFA have been demonstrated, such as patient preference, lower complication rates, early ambulation, and shorter hospital stay. However, studies reporting the safety and efficacy of this approach for peripheral vascular interventions performed by interventional radiologists are relatively few. This review aimed to summarize the technique and clinical applications of TRA in percutaneous transcatheter visceral artery embolization and the management of complications.

show abstract

Section: Clinical Applications Transarterial Chemoembolization For Hementioning

confidence: 99%

“…7). Pua et al (30) reported successful cone-beam CT acquisition during the stopped. Then, the air is slowly deflated until a strong radial pulse is palpated or until bleeding is observed at the access site.…”

Section: Clinical Applications Transarterial Chemoembolization For Hementioning

confidence: 99%

Update on Transradial Access for Percutaneous Transcatheter Visceral Artery Embolization

et al. 2021

View full text Add to dashboard Cite

show abstract

“…20,[25][26][27][28] So far, cone-beam or interventional radiology angiography computed tomography systems can construct three-dimensional reconstruction of arteries and support superselective TACE. [29][30][31] Moreover, inserting a catheter into the tumor feeding arteries superselectively leads to the prevention of liver function and reduction in negative side effects. Using a large cohort of patients (n=815), Yamakado et al 32 reported that selective TACE contributed to survival outcomes in patients who received TACE (hazard ratio, 0.68; 95% confidence interval, 0.48-0.97; P=0.033).…”

Section: Reconsideration Of Tace From the Cur-rent Perspectivementioning

confidence: 99%

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

et al. 2020

View full text Add to dashboard Cite

In patients with unresectable hepatocellular carcinoma (HCC) without both macrovascular invasion and extrahepatic metastasis, the initial treatment choice recommended is transarterial chemoembolization (TACE). Before sorafenib came into wide use, TACE had been pointlessly carried out repeatedly. It was in the early 2010s that the concept of TACE refractory was advocated. Two retrospective studies from Japan indicated that conversion from TACE to sorafenib the day after patients were deemed as TACE refractory improved overall survival compared with continued TACE, according to the definition by the Japan Society of Hepatology. Nowadays, phase 3 trials have shown clinical benefits of several novel molecular target agents. Compared with the era of sorafenib, sequential treatments with these molecular target agents have gradually prolonged patients’ survival and have become major strategies in patients with HCC. Taking these together, conversion from TACE to systemic therapies at the time of TACE refractory, compared with before, may have a greater impact on survival and may be considered deeper in the decisions-making process in patients with unresectable HCC who are candidate for TACE. Up-to-date information on the concept of TACE refractory is summarized in this review. We believe that the survival of patients with unresectable HCC without both macrovascular invasion and extrahepatic metastasis may be dramatically improved by optimal timing of TACE refractory and switching to systemic therapies.

show abstract

Feasibility Study of “Snuffbox” Radial Access for Visceral Interventions

Pua

Sim

Quek

et al. 2018

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

Cone-beam CT acquisition during transradial TACE made easy; use of the swivel arm board

Cited by 3 publications

References 6 publications

Update on Transradial Access for Percutaneous Transcatheter Visceral Artery Embolization

Update on Transradial Access for Percutaneous Transcatheter Visceral Artery Embolization

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

Feasibility Study of “Snuffbox” Radial Access for Visceral Interventions

Contact Info

Product

Resources

About